Rahman Ravelli
Rahman Ravelli Solicitors Logo
Rapid Response Team: 0800 559 3500
Switchboard: +44 (0)203 947 1539
 Request a Callback
Our Services Sectors International About Us Legal Articles News Contact Us
Rapid Response Team: 0800 559 3500
International: +44 (0)203 947 1539
Rapid Response Team: 0800 559 3500
International: +44 (0)203 947 1539
 

/ News / Shares of pharmaceutical giant Valeant have been falling after a research firm accused it of large-scale fraud

Shares of pharmaceutical giant Valeant have been falling after a research firm accused it of large-scale fraud



Federal prosecutors were already probing the way the Canadian company prices and distributes its drugs. Now Citron, a firm that actively bets against stocks and publishes negative research on companies, is claiming that Valeant could be the “pharmaceutical Enron.”

Citron believes a “web of deception” has involved creating “invoices to deceive auditors and book revenue.” Valeant has said the claims are erroneous, false and misleading and intended to manipulate the market.

The only way this can be settled is by investigators trawling through the masses of documentation available. It will then be an issue of who can make the strongest case from the evidence at their disposal.

Shares of pharmaceutical giant Valeant have been falling after a research firm accused it of large-scale fraud

Rahman Ravelli Solicitors

Serious Fraud, Regulatory and Complex Crime Lawyers

enquiries@rahmanravelli.co.uk
0800 559 3500 -

Request a Callback

London Office: +44 (0)203 947 1539
Midlands Office: +44 (0)121 827 7985
Northern Office: +44 (0)1422 346 666
24hr Rapid Response: 0800 559 3500

Need Help or Advice?

Share this article on